as on February 6, 2026 at 9:31 pm IST
Day's Low
Day's High
2.19%
Downside
0.34%
Upside
52 Week's Low
52 Week's High
40.61%
Downside
18.65%
Upside
as on February 6, 2026 at 4:01 pm IST
Market Cap
₹7,943.44 Cr
Return on Equity (ROE)
85.9
PE Ratio (TTM)
15.53
Return on capital employed (ROCE)
4.62
Industry PE ratio
40.92
Beta (LTM)
1.28
P/B Ratio
1.93
Dividend Yield
0.6
PEG Ratio
-0.13
Quarterly Earnings Growth YOY
131.14
EPS (TTM)
390.34
Sector
Pharmaceuticals
Book Value
276.88
Technical Analysis
Bearish
View Technical Analysis
as on February 6, 2026 at 4:01 pm IST
Strides Pharma in the last 5 years
Lowest (-409.06x)
July 5, 2021
Today (15.53x)
February 5, 2026
Industry (40.92x)
February 5, 2026
Highest (1089.10x)
January 7, 2021
Today’s Price to Earnings Ratio: 15.53x
Compare market cap, revenue, PE, and other key metrics of Strides Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 7,943.44 | 0.56% | 0.72 | 3,597 | 4,565 | |
| NA | 380.75 | 24.02% | 0.68 | 18 | 344 | |
| BUY | 4,046.37 | 6.12% | 0.63 | 128 | 1,243 | |
| NA | 394.44 | 9.64% | 0.00 | -2 | 159 | |
| NA | 3,579.51 | 179.39% | 0.00 | 48 | 150 |
Based on 3 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Strides Pharma. Average target price of ₹1083.33
Source: S&P Global Market Intelligence
Get share price movements and forecasts by analysts on Strides Pharma.
What analysts predicted
25.71%UPSIDE
Target Price
₹1083.33
Current Price
₹863.9
Analyzed by
3 Analysts
High
₹1228
Target
₹1083.33
Low
₹937
Strides Pharma target price ₹1083.33, a slight upside of 25.71% compared to current price of ₹863.9. According to 3 analysts rating.
Source: S&P Global Market Intelligence
Investment in Strides Pharma Science Ltd Shares on INDmoney has grown by 135.56% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:135.56% versus previous 30 day period
Search interest for Strides Pharma Science Ltd Stock has increased by 34% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:34% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Strides Pharma.
Strides Pharma Science Ltd’s net profit jumped 129.8% since last year same period to ₹202.11Cr in the Q3 2025-2026. On a quarterly growth basis, Strides Pharma Science Ltd has generated 58.48% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Strides Pharma Science Ltd has declared dividend of ₹4.00 per share on 22 May 2025 - translating a dividend yield of 0.75%.
Read More about DividendsCheck stock indices that include Strides Pharma.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
MF Holding Up
![]()
Mutual Funds have increased holdings from 8.48% to 8.59% in Dec 2025 quarter
Best in 3 Years
![]()
In the last 3 years, STAR has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 1.12K Cr → 1.30K Cr (in ₹), with an average increase of 6.9% per quarter
FII Holding Up
![]()
Foreign Institutions have increased holdings from 28.51% to 29.52% in Dec 2025 quarter
Profit Spike
![]()
Netprofit is up for the last 4 quarters, 82.19 Cr → 202.11 Cr (in ₹), with an average increase of 25.4% per quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 27.86% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 25.8% return, outperforming this stock by 7.6%
Price Dip
![]()
In the last 1 month, STAR stock has moved down by -12.5%
Retail Holding Down
![]()
Retail Investor have decreased holdings from 30.64% to 29.59% in Dec 2025 quarter
| Organisation | Strides Pharma Science Ltd |
| Headquarters | Bangaluru |
| Industry | Pharmaceuticals |
| CEO | Arun Kumar |
| E-voting on shares | Click here to vote |
Strides Pharma share price today stands at ₹863.9 as on at the close of the market. Strides Pharma share today touched a day high of ₹866.85 and a low of ₹845.
Strides Pharma touched a 52 week high of ₹1025 and a 52 week low of ₹513.05. Strides Pharma share price today i.e. is closed at ₹863.9, which is -15.72% down from its 52 week high and 68.39% up from its 52 week low.
Strides Pharma market capitalisation is ₹7,943.44 Cr as on .
To buy Strides Pharma shares, you need to follow these steps:
Strides Pharma trading volume is 1.69L as on . This means that 1.69L shares of Strides Pharma were bought and sold on the stock market during today's trading session.